Shares of La-Z-Boy Inc (NYSE:LZB) rose sharply in pre-market trading after the company after the company reported better-than-expected fourth-quarter financial results and announced a $300 million share buyback.

EPS for the quarter for La-Z-Boy in the fourth quarter came in at $1.26, crushing the analyst estimate of 82 cents. The company posted a revenue of $570.34 million, surpassing the estimate of $569.23 million

La-Z-Boy shares jumped 19.6% to $41.94 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• Lunai Bioworks Inc (NASDAQ:LNAI) gained 153.1% to $7.20 in pre-market trading after the AI-powered biotechnology and biodefense company disclosed via a Securities and Exchange Commission filing that Nasdaq confirmed it had regained compliance with the exchange's minimum bid price requirement of $1.00 per share.
• NewGenIvf Group Ltd (NASDAQ:NIVF) rose 102.7% to $1.42 in pre-market trading after gaining 20% on Tuesday. NewGen eliminated convertible note and warrant overhang with a significant investor, entering into settlement agreement strengthening capital structure.
• Cre8 Enterprise Ltd (NASDAQ:CRE) gained 59% to $5.20 in pre-market trading after adding 4% on Tuesday.
• Sadot Group Inc (NASDAQ:SDOT) gained 53.3% to $13.30 in pre-market trading after dipping 63% on Tuesday.
• Micropolis Holding Company (NYSE:MCRP) jumped 44.2% to $3.00 in pre-market trading after the UAE-based autonomous robotics developer announced a five-year agreement with Abu Dhabi's Department of Municipalities and Transport.
• Regentis Biomaterials Ltd (NYSE:RGNT) rose 39.3% to $8.50 in pre-market trading after declining around 35% on Tuesday. Regentis Biomaterials recently announced it had filed a request with the SEC to withdraw its Form F-1 registration statement and decided not to proceed with the proposed public offering.
• Tianci International Inc (NASDAQ:CIIT) gained 38.9% to $0.61 in pre-market trading after dipping 70% on Tuesday. Tianci said it priced a registered offering of 6.05 million units at $0.81 per unit, expected to raise approximately $4.9 million in gross proceeds.
• Golden Heaven Group Holdings Ltd (NASDAQ:GDHG) rose 33% to $2.13 in pre-market trading.
• Standard Biotools Inc (NASDAQ:LAB) gained 10.7% to $0.92 in pre-market trading.

Losers

• Aditxt Inc (NASDAQ:ADTX) tumbled 27.5% to $0.0079 in pre-market trading after a new SEC Form 4 filing showed major shareholder HRT Financial LP purchased millions of shares.
• Liberty Latin America Ltd (NASDAQ:LILA) fell 26.7% to $5.71 in pre-market trading.
• Star Fashion Culture Holdings Ltd (NASDAQ:STFS) fell 22.8% to $6.31 in pre-market trading.
• Myseum AI Inc (NASDAQ:MYSE) declined 16.4% to $1.92 in pre-market trading. Myseum.AI announced it signed a Non-Binding Letter of Intent with Scanon.ai Systems to explore a development partnership for AI-powered social media content moderation and management intelligence tools.
• Interactive Strength Inc (NASDAQ:TRNR) fell 16.1% to $0.61 in pre-market trading after jumping 37% on Tuesday. Interactive Strength affirmed preliminary second-quarter sales guidance of $8.000 million, versus market estimates of $5.157 million.
• Veraxa Biotech AG (NASDAQ:VRXA) fell 12.4% to $8.29 in pre-market trading after declining 59% on Tuesday.
• Nexentis Technologies Inc (NASDAQ:NXTS) fell 10.7% to $5.20 in pre-market trading after gaining 5% on Tuesday.
• SL Science Holding Ltd (NASDAQ:SLBT) declined 10.4% to $7.95 in pre-market trading after surging 167% on Tuesday.
• Qualys Inc (NASDAQ:QLYS) shares dipped 5.6% to $107.26 in pre-market trading.
• Lionsgate Studios Corp (NYSE:LION) fell 4.7% to $15.60 in pre-market trading after jumping 14% on Tuesday.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.